Why Foreign Capital Is Buying UK Insurance

Introduction — Why London's Insurance Market Has Become a Global Acquisition Target

The United Kingdom is home to the world's oldest continuously operating insurance market, one of its deepest pools of pension risk transfer capital, and the only market infrastructure capable of pricing and distributing genuinely global specialty risk at scale. It is also, increasingly, a market whose most strategically important companies are being bought by foreign capital at significant premiums to their listed prices — premiums that, by definition, reflect the gap between what UK public markets are willing to pay and what global strategic buyers believe these assets are worth.

That gap is the subject of this note.

The causes of the UK equity market discount are structural and well-documented. UK pension funds, which once provided a stable domestic equity base, have spent the past two decades systematically de-equitising — shifting into bonds, liability-driven investments, and alternative assets as they sought to match long-dated liabilities. By 2024, UK equity funds held only 27% of total net assets, compared with 78% in 2004. Retail participation has remained chronically low. Analyst coverage of mid-cap insurers has thinned. And the FTSE 100, increasingly weighted toward legacy sectors with limited growth profiles, has struggled to attract the international capital flows that have enriched US and European equity markets. Against that backdrop, UK equity outflows hit their worst recorded level in 2025, with £6.7 billion withdrawn from open-ended equity funds — more than double the previous record — even as the FTSE 100 reached all-time highs.

For insurance companies, those conditions have produced a specific and persistent problem. The market has come to value them primarily as income stocks: dividend-yielding, low-growth financials to be held for yield rather than strategic optionality. That framing is not entirely wrong — many UK insurers do generate strong, predictable cash flows. But it systematically undervalues what foreign buyers are actually acquiring.

Global strategic acquirers — whether European composite insurers seeking specialty scale, Japanese groups seeking international diversification, or alternative asset managers seeking permanent capital — increasingly view UK insurance companies as something else entirely: regulated infrastructure assets with long-duration balance sheets, scarce underwriting franchises, and structural access to the world's most concentrated specialty risk market. Lloyd's capacity is not easily replicated. Bulk purchase annuity origination platforms take years to build. Specialty underwriting expertise is accumulated over decades. These are not the characteristics of a mature income stock. They are the characteristics of a strategic asset with genuine scarcity value.

The deal history makes the argument for itself. Intact and Tryg acquired RSA in 2021. Ageas pursued Direct Line in 2024, losing out to Aviva. Brookfield acquired Just Group for £2.4 billion in 2025. Athora — backed by Apollo — acquired Pension Insurance Corporation for £5.7 billion in the same year. And in early 2026, Zurich sealed its acquisition of Beazley at a 63% premium to the undisturbed share price, explicitly citing the strategic value of Beazley's Lloyd's platform and specialty underwriting capability. As this note was being finalised, reports linked Intact Financial to a potential approach for Hiscox, sending its shares to record highs. Meanwhile, Apollo, Brookfield, Blackstone, and CVC have all been associated — with varying degrees of specificity — with possible interest in Legal & General.

What is happening here is not a cycle. It is ownership migration. And it raises a question that the industry, regulators, and investors should be taking more seriously than the deal-by-deal commentary suggests: are UK public markets still capable of properly valuing — and retaining — the globally important insurance franchises that have been built here?

Section I — Why UK Insurers Trade Cheaply

The UK equity market discount on insurance companies is not primarily a function of business quality. Most of the companies being acquired — or linked to acquisition rumours — are demonstrably well-run, with strong underwriting disciplines, improving returns, and credible growth strategies. The discount is structural, and it operates through several interconnected mechanisms.

The most consequential is the collapse of domestic institutional demand. UK pension funds, once the bedrock of FTSE equity ownership, have systematically reduced their equity allocations over the past two decades as they moved to liability-driven investment strategies. That process is now largely complete for defined benefit schemes, and its legacy is a domestic equity market that lacks the natural long-term buyers that sustain premium valuations elsewhere. The capital that once supported FTSE 100 insurance companies at high multiples has been reallocated — into gilts, investment-grade credit, and infrastructure — by the very pension schemes those insurers now serve through the bulk purchase annuity market.

The structural withdrawal of pension capital has been compounded by a broader deterioration in UK retail participation. Unlike US households, which channel significant savings into domestic equities through 401(k) and IRA structures, UK retail investors have shown limited appetite for domestically-listed financial stocks. In the 55 months to early 2026, only one saw net inflows to UK-focused equity funds. Active fund managers, who might once have provided analytical support and long-term ownership, have seen persistent outflows. Analyst coverage of mid-cap insurers has consequently thinned — reducing price discovery and increasing the likelihood that stocks trade at technically-driven rather than fundamentals-driven valuations.

The result is a valuation gap that shows up most clearly in the comparison between UK-listed insurers and their overseas-listed peers. UK life insurers were trading at approximately nine times 2026 earnings in early 2025 — with dividend yields of 8–9% in some cases — despite forecast earnings-per-share growth of around 10%. Those multiples are materially below the levels at which comparable European and US peers trade, reflecting not a difference in underlying business quality but a difference in the market context in which they are held.

The valuation mechanics matter because they create a self-reinforcing dynamic. Low multiples depress the cost at which foreign buyers can acquire UK assets. High dividend yields signal to the market that management is returning capital rather than reinvesting for growth — which is rational for a business priced as an income stock but may be suboptimal for a business with genuine strategic expansion opportunities. And depressed valuations reduce the capacity of UK-listed companies to make their own acquisitions at competitive prices, gradually ceding the consolidation agenda to better-capitalised foreign buyers.

There is also a perception problem that is partly a function of index composition. The FTSE 100 is disproportionately weighted toward sectors — energy, mining, consumer staples — that international growth investors tend to underweight. UK financial stocks, including insurers, tend to be grouped into the "value" or "income" bucket by global allocators, reducing the probability that they will attract the growth-premium multiples that comparable businesses might command if listed in New York or Amsterdam. That is not a reflection of the underlying businesses. It is a structural feature of where they happen to be listed.

Section II — Why Foreign Buyers Value Insurance Assets Differently

The valuation gap only makes sense if foreign buyers have a materially different frame for what they are acquiring. They do — and understanding that frame is central to the argument of this note.

For traditional insurance acquirers — European composites, large Japanese groups, North American P&C platforms — the strategic logic of UK acquisitions centres on two things that cannot easily be built from scratch: access to global specialty distribution and access to scarce regulated infrastructure. Zurich's rationale for acquiring Beazley was stated explicitly: it creates a combined specialty platform writing roughly $15 billion of gross written premiums, anchored by Beazley's Lloyd's access and established cyber, marine, and specialty franchises. Intact's reported interest in Hiscox follows a similar logic — the Canadian insurer has already acquired RSA to build UK commercial lines scale, and Hiscox's Lloyd's platform and SME retail infrastructure would extend that position significantly. These buyers are not simply acquiring earnings streams. They are acquiring market positions and platforms that would take decades and hundreds of millions of pounds to replicate organically.

The second and analytically more interesting class of buyer is the alternative asset manager. Apollo's model — acquiring or partnering with insurance companies to gain access to a permanent, low-cost liability base that can fund private credit and alternative investments — has been the most consequential development in global insurance M&A over the past decade. The economics are compelling: annuity liabilities, once written, are extraordinarily stable; they pay out over decades on predictable longevity curves; and the capital they generate can be deployed into private credit, infrastructure, and real assets at spreads materially above public investment-grade bonds. The Solvency UK reforms, which have relaxed the matching adjustment rules governing what assets can back annuity liabilities, have made UK-domiciled annuity platforms even more attractive for this purpose — expanding the range of eligible assets and increasing the spread income available to a sophisticated asset manager with the capability to originate private credit at scale.

This is why Apollo, through Athora, acquired PIC, and why the same logic attaches to L&G. The £50+ billion annuity book at L&G is not simply a source of insurance underwriting profit. It is, from a strategic buyer's perspective, a scalable, regulated, and growing pool of long-duration capital that can anchor a broader private credit and alternatives platform. Brookfield's acquisition of Just Group follows identical logic — Just is a specialist annuity writer with a growing BPA book, and Brookfield's willingness to pay a substantial premium reflects its assessment of the long-term asset management economics that come with the balance sheet, not merely the insurance underwriting returns visible on the income statement.

Section III — The UK Insurance Ownership Shift: A Pattern, Not a Wave

Viewed sequentially, the recent transactions look like an accelerating wave of foreign M&A. Viewed historically, they look like the latest phase of a longer-running ownership transition that has been reshaping the UK insurance sector for more than fifteen years.

Several features of this timeline deserve attention. First, the buyers are diverse — Scandinavian, Canadian, American, Swiss, and alternative capital — which indicates that the attraction of UK insurance assets is not region-specific or driven by any single strategic logic. Second, the deal sizes have grown: the transactions of 2025–2026 are materially larger than those of 2011–2015, reflecting both the increased confidence of foreign buyers and the premium they are willing to pay for scale and market position. Third, and most importantly, the strategic rationale has evolved. Early acquisitions were largely about specialty underwriting and Lloyd's access. The most recent ones increasingly reflect a view of UK insurance as a capital origination and asset management platform.

What has changed since 2021 is the velocity and the buyer profile. The RSA transaction set a template. It demonstrated that UK public market shareholders would accept significant premiums, that regulators would permit strategic consolidation, and that acquired UK platforms could be integrated successfully into global structures. The success of that transaction — Intact's UK commercial lines business has performed well under its ownership — reduced the perceived risk for subsequent buyers. It also reduced the political and regulatory uncertainty that foreign acquirers had previously cited as a reason for caution.

The Solvency UK reforms have added further impetus specifically for alternative capital buyers. By expanding the asset classes eligible for the matching adjustment — the regulatory tool that allows annuity writers to take credit for higher spreads on illiquid assets — the PRA has materially improved the economics of UK annuity platforms for any acquirer with the private credit origination capability to exploit them. Apollo, Brookfield, and their peers are exactly such acquirers. The reforms have, in effect, made UK BPA books more strategically valuable to alternative asset managers than they were under the original Solvency II framework.

Case Study II — Legal & General: The Balance Sheet as the Business

Legal & General is a different kind of problem. It is not primarily an insurance company in the sense that Hiscox or Beazley are — businesses whose strategic value is anchored in underwriting expertise and specialty market access. L&G is an asset origination and capital management business that happens to use an insurance balance sheet as its primary funding vehicle. Understanding that distinction is essential to understanding why it has attracted the attention it has.

The business is approximately 60% annuity-related, with a BPA platform that is one of the three largest in the UK market alongside PIC and Rothesay. The bulk purchase annuity market has been growing rapidly: LCP projected over 350 transactions in 2025, with volumes exceeding £40 billion for a third consecutive year, and the PRA's own analysis suggested aggregate deal values could exceed £60 billion by 2027. L&G has been one of the most active participants in that market for years. Its BPA platform generates returns on Solvency II own funds of 9–10% — broadly in line with peers — and the forward pipeline is structurally strong given the funding position of UK defined benefit pension schemes, over half of which are now in surplus on a buyout basis. (LCP; ABI; PRA)

The strategic appeal of L&G to a buyer like Apollo, Brookfield, or Blackstone is not the 9–10% return on Solvency II own funds — though that is creditable. It is the scale of the liability base and the asset allocation flexibility that comes with it. An alternative asset manager with a strong private credit origination capability can deploy the capital backing L&G's annuity book into infrastructure debt, real estate debt, private corporate loans, and other illiquid assets at spreads significantly above public credit — generating excess returns that are not available to a traditional insurance investor constrained by public market allocation. The Solvency UK matching adjustment reforms have expanded the eligible asset universe for exactly this purpose, and L&G's own Asset Management division has been building private credit origination capability for years.

The model being contemplated — taking L&G private or into a hybrid ownership structure with alternative capital — would essentially replicate what Apollo did with Athene, what KKR did with Global Atlantic, and what Brookfield did with both American National and, most recently, Just Group. In each case, the acquirer used the insurance balance sheet as a captive asset management platform, routing its private credit and alternatives pipeline through the insurer's investment book, generating fee income and returns enhancement that the public market structure did not permit.

The obstacles to a full acquisition of L&G are real, and should not be dismissed. The company holds a significant proportion of UK gilts; it is a major counterparty to UK pension schemes; and its regulatory capital position means that any change of control triggers deep PRA scrutiny and, given the systemic importance of the business, likely Treasury and Bank of England engagement. L&G's CEO António Simões has stated clearly that no discussions are under way, and the company has publicly committed to its current strategic direction. But the fact that multiple of the world's most sophisticated capital allocators are reportedly spending serious money on analysis of a potential approach is itself informative. The FT quoted one US private capital executive describing the situation as "getting pretty real." That is not idle chatter.

The more likely near-term scenario — absent a full bid — is a deepening of the Blackstone partnership into something closer to an equity interest, following the Athene template. L&G already routes significant private asset allocation through Blackstone. Extending that relationship to include equity ownership of the asset management operation, or establishing a captive asset management vehicle for the annuity book, would deliver much of the strategic value of a full acquisition at lower regulatory and execution risk. That is, in effect, how the Apollo/Athene model evolved — through progressive partnership deepening before full integration.

Section IV — What This Means for London Markets

The individual transactions are consequential enough on their own terms. Taken together, they raise a question that is harder to answer: what does it mean for the UK if London public markets can no longer retain ownership of the insurance sector it has built over three centuries?

The immediate implications are relatively well-understood. As assets leave the public market — either through outright acquisition or progressive privatisation — the remaining pool of publicly-listed UK insurers becomes smaller, less liquid, and less well-covered. That makes the surviving companies more vulnerable to similar valuation discounts, and therefore more vulnerable to subsequent acquisition on similar terms. The dynamic is self-reinforcing. Beazley's departure from the FTSE 100 removes one of the largest and most internationally visible UK specialty insurers from the public market permanently. If Hiscox follows, the London-listed Lloyd's market sector essentially disappears as a public equity asset class.

The second-order effects are less visible but potentially more significant. The Lloyd's market depends, in part, on the concentration of underwriting expertise, capital, and risk-taking capability in London. If major Lloyd's participants — Beazley is now certain; Hiscox is possible — are owned by overseas groups whose primary strategic interests and capital allocation decisions are made elsewhere, the question arises whether London remains the natural home for the talent and intellectual capital that makes the Lloyd's market function at its current level of sophistication. This is not an argument that foreign ownership is inherently harmful — Zurich and Intact are credible, well-capitalised operators with clear strategic commitments to UK operations. But it is an observation that ownership matters for long-term strategic investment decisions in ways that are not immediately visible in deal announcements.

The third consideration is regulatory and financial sovereignty. L&G, specifically, sits in a different category from the specialty insurers. It is a systemically important institution with significant holdings of UK government debt and a major role in the defined benefit pension de-risking market. The PRA and Treasury are clearly aware of the strategic sensitivity of a potential ownership change. That awareness may be sufficient to prevent a transaction — or it may simply shape the terms on which one occurs. What it will not do is resolve the underlying valuation gap that makes such transactions commercially attractive to potential buyers.

There are no straightforward remedies. The pension fund de-equitisation that removed the natural domestic buyer base is structurally irreversible. The retail participation gap is cultural as much as structural. Listing rule reforms and initiatives to attract domestic savings back into equities may help at the margin, but they operate over long timeframes and against persistent headwinds. The more immediate question for boards, regulators, and market participants is whether there are structures — potentially including hybrid ownership models, enhanced partnership agreements with strategic investors, or revised capital return frameworks — that can narrow the valuation gap sufficiently to reduce the incentive for full acquisition.

That is a question the industry needs to take seriously, because the current trajectory ends in a straightforward place: a UK insurance sector that is operationally present in London but strategically owned elsewhere.

Conclusion — The Valuation Gap and What Follows From It

The argument of this note comes down to a straightforward observation: UK public markets and global strategic buyers are looking at the same insurance companies and reaching different conclusions about what they are worth. The gap between those conclusions has been wide enough, and persistent enough, to produce more than £16 billion of agreed UK insurance acquisitions in the space of twelve months — at premiums that, in Beazley's case, exceeded 60% to the undisturbed market price and 34% to the business's own all-time high.

The valuations being applied by foreign buyers are not irrational. They reflect a coherent and well-evidenced view that UK insurance companies contain strategic assets — Lloyd's infrastructure, specialty underwriting expertise, long-duration annuity liabilities, private credit origination platforms, regulated balance sheets — that cannot easily be replicated and that have value well in excess of what a dividend-yield or earnings-multiple framework captures. The valuations applied by UK public markets are not irrational either. They reflect the structural realities of a domestic equity market that has experienced persistent outflows, declining institutional ownership, and a gravitational pull toward the income characteristics of large, mature financial companies.

The critical question is whether the gap is temporary or structural. There are reasons to think it is more structural than cyclical. The pension fund de-equitisation that removed the UK's natural long-term equity buyer base is not reversible. The FTSE 100's composition bias toward value and income sectors is not easily corrected. The alternative asset management industry's appetite for insurance balance sheets as capital platforms is, if anything, growing — as the Solvency UK reforms make UK annuity books more useful to sophisticated asset managers, and as global private credit demand continues to expand the economic case for accessing permanent capital through insurance. The conditions that created this valuation gap are not resolving. They are deepening.

That does not mean every UK insurer will be acquired. Regulatory constraints — particularly around systemic institutions like L&G — are real, and the PRA and Treasury will scrutinise any ownership change carefully. Management teams have options: capital returns, strategic partnerships, and asset management restructurings that can partially close the gap without a change of control. And the public market is not entirely static — Hiscox's share price has risen sharply on takeover speculation, suggesting that the market can re-rate toward strategic value when it is given a reason to do so.

But the broader trend is clear. The UK insurance sector — which was built over centuries, which houses the world's only Lloyd's market, and which manages the retirement savings of millions of UK citizens — is progressively transferring to foreign and private ownership. That is happening not because UK insurers are weak businesses, but because the market in which they are listed has become structurally unable to price them at their strategic value. The question that follows from that observation is not simply a financial one. It is a question about what kind of financial sector the UK wants to have, and whether the institutions and policies in place are adequate to the task of retaining it.

The answer, at present, is not reassuring.